Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients - PubMed (original) (raw)

Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients

T Aoyama et al. J Clin Invest. 1995 Jun.

Abstract

Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) was purified from human liver. The molecular masses of the native enzyme and the subunit were estimated to be 154 and 70 kD, respectively. The enzyme was found to catalyze the major part of mitochondrial palmitoylcoenzyme A dehydrogenation in liver, heart, skeletal muscle, and skin fibroblasts (89-97, 86-99, 96-99, and 78-87%, respectively). Skin fibroblasts from 26 patients suspected of having a disorder of mitochondrial beta-oxidation were analyzed for VLCAD protein using immunoblotting, and 7 of them contained undetectable or trace levels of the enzyme. The seven deficient fibroblast lines were characterized by measuring acyl-coenzyme A dehydrogenation activities, overall palmitic acid oxidation, and VLCAD protein synthesis using pulse-chase, further confirming the diagnosis of VLCAD deficiency. These results suggested the heterogenous nature of the mutations causing the deficiency in the seven patients. Clinically, all patients with VLCAD deficiency exhibited cardiac disease. At least four of them presented with hypertrophic cardiomyopathy. This frequency (> 57%) was much higher than that observed in patients with other disorders of mitochondrial long-chain fatty acid oxidation that may be accompanied by cardiac disease in infants.

PubMed Disclaimer

Similar articles

• Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
  Djouadi F, Aubey F, Schlemmer D, Ruiter JP, Wanders RJ, Strauss AW, Bastin J. Djouadi F, et al. Hum Mol Genet. 2005 Sep 15;14(18):2695-703. doi: 10.1093/hmg/ddi303. Epub 2005 Aug 22. Hum Mol Genet. 2005. PMID: 16115821
• A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.
  Aoyama T, Uchida Y, Kelley RI, Marble M, Hofman K, Tonsgard JH, Rhead WJ, Hashimoto T. Aoyama T, et al. Biochem Biophys Res Commun. 1993 Mar 31;191(3):1369-72. doi: 10.1006/bbrc.1993.1368. Biochem Biophys Res Commun. 1993. PMID: 8466512
• Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
  Liebig M, Schymik I, Mueller M, Wendel U, Mayatepek E, Ruiter J, Strauss AW, Wanders RJ, Spiekerkoetter U. Liebig M, et al. Pediatrics. 2006 Sep;118(3):1065-9. doi: 10.1542/peds.2006-0666. Pediatrics. 2006. PMID: 16950999
• Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
  Gregersen N, Andresen BS, Corydon MJ, Corydon TJ, Olsen RK, Bolund L, Bross P. Gregersen N, et al. Hum Mutat. 2001 Sep;18(3):169-89. doi: 10.1002/humu.1174. Hum Mutat. 2001. PMID: 11524729 Review.

Cited by

• Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation.
  Doulias PT, Tenopoulou M, Greene JL, Raju K, Ischiropoulos H. Doulias PT, et al. Sci Signal. 2013 Jan 1;6(256):rs1. doi: 10.1126/scisignal.2003252. Sci Signal. 2013. PMID: 23281369 Free PMC article.
• Diet-sensitive sources of reactive oxygen species in liver mitochondria: role of very long chain acyl-CoA dehydrogenases.
  Cardoso AR, Kakimoto PA, Kowaltowski AJ. Cardoso AR, et al. PLoS One. 2013 Oct 7;8(10):e77088. doi: 10.1371/journal.pone.0077088. eCollection 2013. PLoS One. 2013. PMID: 24116206 Free PMC article.
• Interplay between oxidant species and energy metabolism.
  Quijano C, Trujillo M, Castro L, Trostchansky A. Quijano C, et al. Redox Biol. 2016 Aug;8:28-42. doi: 10.1016/j.redox.2015.11.010. Epub 2015 Nov 30. Redox Biol. 2016. PMID: 26741399 Free PMC article. Review.
• Fatty Acid Accumulation and Resulting PPARα Activation in Fibroblasts due to Trifunctional Protein Deficiency.
  Wakabayashi M, Kamijo Y, Nakajima T, Tanaka N, Sugiyama E, Yangyang T, Kimura T, Aoyama T. Wakabayashi M, et al. PPAR Res. 2012;2012:371691. doi: 10.1155/2012/371691. Epub 2012 May 8. PPAR Res. 2012. PMID: 22654897 Free PMC article.
• Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.
  Kanbe H, Kamijo Y, Nakajima T, Tanaka N, Sugiyama E, Wang L, Fang ZZ, Hara A, Gonzalez FJ, Aoyama T. Kanbe H, et al. Arch Toxicol. 2014 Feb;88(2):367-79. doi: 10.1007/s00204-013-1132-3. Epub 2013 Sep 25. Arch Toxicol. 2014. PMID: 24065054 Free PMC article.

References

1. 1. Pediatr Res. 1991 Sep;30(3):211-5 - PubMed
2. 1. Pediatr Neurol. 1991 Mar-Apr;7(2):125-30 - PubMed
3. 1. Am J Hum Genet. 1991 Dec;49(6):1280-91 - PubMed
4. 1. Ann Neurol. 1991 Nov;30(5):709-16 - PubMed
5. 1. J Biol Chem. 1992 Jan 15;267(2):1027-33 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Society for Clinical Investigation
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal